Exacerbation indicators in patients with noninvasive home ventilatio

• Conditions: J44.0; J96.11; Chronic obstructive pulmonary disease with acute lower respiratory infection

• Registration Number: DRKS00029273
• Lead Sponsor: Kliniken der Stadt Köln gGmbH, Lungenklinik Standort-Merheim

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-06-13
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 85

Inclusion Criteria

Patients with pre-existing COPD of any stage according to GOLD with established NIV therapy.
- Consent to privacy policy and patient education
- Cognitive and verbal ability to answer the questionnaires

Exclusion Criteria

- Patient age <18 years
- Deafness, Alexia
- Not able to give consent

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary descriptive: comparison of NIV device data and telemonitoring data from patients with COPD exacerbation on existing NIV therapy.

Secondary Outcome Measures

Name	Time	Method
1. symptom documentation before and after exacerbation event.<br>2. identification of breathing patterns in device data and corresponding symptom patterns.